In a microarray analysis of the serum of non-small cell lung cancer patients, miRNA223 was found to be down-expressed compared to healthy individuals, and its high level suppresses the expression of EGFR protein40. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.